We are live on
!
Find out more
NC
Nicholas Company Portfolio holdings
AUM
$5.47B
1-Year Est. Return
16.96%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.4B
AUM Growth
-$200M
(-4.3%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-5.09%
Top 10 Holdings %
Top 10 Hldgs %
21.56%
Holding
225
New
15
Increased
38
Reduced
133
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$32M |
| 2 |
Boston Scientific
BSX
|
+$23M |
| 3 |
Vulcan Materials
VMC
|
+$9.52M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$7.8M |
| 5 |
Polaris
PII
|
+$7.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AptarGroup
ATR
|
+$31.6M |
| 2 |
NLSN
Nielsen Holdings plc
NLSN
|
+$29.7M |
| 3 |
AGN
Allergan plc
AGN
|
+$24.4M |
| 4 |
Merck
MRK
|
+$21.6M |
| 5 |
Cisco
CSCO
|
+$18.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Healthcare | 15.73% |
| 3 | Financials | 15.43% |
| 4 | Industrials | 14.88% |
| 5 | Consumer Discretionary | 14.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Thermo Fisher Scientific
TMO
$230B
| $113M | 2.57% |
546,759
-28,780
| -5% | -$6.04M |
|
2
CBRE Group
CBRE
$43.7B
| $103M | 2.35% |
2,190,245
-42,325
| -2% | -$1.93M |
|
3
Microsoft
MSFT
$3.81T
| $101M | 2.29% |
1,102,555
-64,235
| -6% | -$5.87M |
|
|
4
Cisco
CSCO
$433B
| $95.9M | 2.18% |
2,236,015
-438,040
| -16% | -$18.6M |
|
|
SCHW
5
Charles Schwab
SCHW
$191B
| $94.2M | 2.14% |
1,803,620
-208,965
| -10% | -$11.2M |
|
6
Mastercard
MA
$521B
| $93.9M | 2.14% |
536,235
-73,140
| -12% | -$12.5M |
|
7
Apple
AAPL
$4.67T
| $90.5M | 2.06% |
2,156,460
+18,900
| +0.9% | +$814K |
|
8
Snap-on
SNA
$20.3B
| $89.5M | 2.03% |
606,365
-14,085
| -2% | -$2.31M |
|
9
Intel
INTC
$473B
| $85.6M | 1.95% |
1,644,480
-65,790
| -4% | -$3.13M |
|
10
LKQ Corp
LKQ
$6.46B
| $82.2M | 1.87% |
2,164,842
-39,465
| -2% | -$1.6M |
|
11
Fastenal
FAST
$57.1B
| $82.1M | 1.87% |
6,012,840
-125,420
| -2% | -$1.73M |
|
12
Affiliated Managers Group
AMG
$9.59B
| $75.1M | 1.71% |
395,980
-9,010
| -2% | -$1.76M |
|
13
Cintas
CTAS
$81.7B
| $74.2M | 1.69% |
1,740,864
-47,076
| -3% | -$1.95M |
|
14
Aon
AON
$75.4B
| $73.4M | 1.67% |
522,775
-12,330
| -2% | -$1.73M |
|
15
Fortive
FTV
$18B
| $68.2M | 1.55% |
1,395,909
-26,578
| -2% | -$1.26M |
|
16
Alphabet (Google) Class C
GOOG
$4.19T
| $65.6M | 1.49% |
1,272,300
+60,900
| +5% | +$3.36M |
|
17
O'Reilly Automotive
ORLY
$71.6B
| $64.2M | 1.46% |
3,893,940
-691,350
| -15% | -$11.7M |
|
18
Home Depot
HD
$329B
| $60.8M | 1.38% |
341,080
-18,150
| -5% | -$3.41M |
|
19
Ball Corp
BALL
$16.9B
| $60.1M | 1.37% |
1,513,152
-35,315
| -2% | -$1.38M |
|
20
Copart
CPRT
$30.5B
| $58.9M | 1.34% |
4,625,360
-1,412,800
| -23% | -$16.3M |
|
21
Philip Morris
PM
$299B
| $56.9M | 1.29% |
572,250
-5,080
| -0.9% | -$529K |
|
22
Visa
V
$712B
| $56.3M | 1.28% |
470,615
-14,850
| -3% | -$1.8M |
|
23
Amazon
AMZN
$2.87T
| $54M | 1.23% |
746,600
-37,000
| -5% | -$2.65M |
|
24
Labcorp
LH
$27.2B
| $52M | 1.18% |
374,534
-47,771
| -11% | -$7.02M |
|
|
WBA
25
DELISTED
Walgreens Boots Alliance
WBA
| $51.2M | 1.16% |
781,795
-22,675
| -3% | -$1.62M |
|
Similar funds
SCM
EI
AP
ENV
ACM
VCM
GCM
TPCW
Nicholas Company's Q1 2018 Portfolio in Review
As of Q1 2018, Nicholas Company held 225 positions worth $4.4B, down 4.3% from $4.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nicholas Company withdrew a net $224M in Q1 2018, closing 14 positions and reducing 133 holdings. Its most notable exit was Allergan plc, an estimated $9.65M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nicholas Company opened a new position in Honeywell worth $30.2M.
- Nicholas Company's largest Q1 2018 buy was Honeywell: 231,357 shares worth $30.2M.
- Nicholas Company added most to Albemarle in Q1 2018, an estimated $6.65M increase.
- Nicholas Company's biggest Q1 2018 reduction was AptarGroup, cutting an estimated $31.6M.
- Nicholas Company fully exited Allergan plc in Q1 2018, selling an estimated $9.65M.
- Nicholas Company's ten largest holdings make up 22% of its $4.4B portfolio in Q1 2018.
- Nicholas Company opened 15 new positions and closed 14 in Q1 2018.
- Nicholas Company's portfolio value fell 4.3% quarter-over-quarter to $4.4B.
Based on Nicholas Company's 13F filing for Q1 2018, filed 14 May 2018.